Fabliha A. Anam

Emory University — United States

Medicine · Health Sciences

9h-index1.3kcitations18works8.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(14), COVID-19 Clinical Research Studies(11), Long-Term Effects of COVID-19(9), T-cell and B-cell Immunology(3), Immunotherapy and Immune Responses(2)

Publications18 total

Publisher Correction: Disease-associated B cells and immune endotypes shape adaptive immune responses to SARS-CoV-2 mRNA vaccination in human SLE
Nature Immunology·2024· 3 citedOpen Access
Disease-associated B cells and immune endotypes shape adaptive immune responses to SARS-CoV-2 mRNA vaccination in human SLE
Nature Immunology·2024· 12 citedOpen Access
MENSA, a Media Enriched with Newly Synthesized Antibodies, to Identify SARS-CoV-2 Persistence and Latent Viral Reactivation in Long-COVID
2024Open Access
MENSA, a Media Enriched with Newly Synthesized Antibodies, to Identify SARS-CoV-2 Persistence and Latent Viral Reactivation in Long-COVID
2024· 6 citedOpen Access
Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunity
Journal of Allergy and Clinical Immunology·2024· 15 citedOpen Access
Patients on Benralizumab, Dupilumab, or Mepolizumab Have Lower Post-vaccination SARS-CoV-2 Immunity
2024
Distinct transcriptomes and autocrine cytokines underpin maturation and survival of antibody-secreting cells in systemic lupus erythematosus
Nature Communications·2024· 26 citedOpen Access
Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID
Nature Communications·2023· 124 citedOpen Access
SLE Antibody-Secreting Cells Are Characterized by Enhanced Peripheral Maturation and Survival Programs
2023· 5 citedOpen Access
Poor immunogenicity upon SARS-CoV-2 mRNA vaccinations in autoimmune SLE patients is associated with pronounced EF-mediated responses and anti-BAFF/Belimumab treatment
2023· 4 citedOpen Access
Dysregulated naive B cells and de novo autoreactivity in severe COVID-19
Nature·2022· 156 citedOpen Access
Reduced SARS-CoV-2 Vaccine Response in Patients Treated with Biologic Therapies for Asthma and Atopic Dermatitis
Journal of Allergy and Clinical Immunology·2022Open Access
Inflammation and autoreactivity define a discrete subset of patients with post-acute sequelae of COVID-19, or long-COVID
2021· 6 citedOpen Access
One-Stop Serum Assay Identifies COVID-19 Disease Severity and Vaccination Responses
ImmunoHorizons·2021· 26 citedOpen Access
Elevated SARS-CoV-2 Antibodies Distinguish Severe Disease in Early COVID-19 Infection
2020· 7 citedOpen Access
Relaxed peripheral tolerance drives broad <i>de novo</i> autoreactivity in severe COVID-19
2020· 70 citedOpen Access
Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19
Nature Immunology·2020· 774 citedOpen Access
Dominant extrafollicular B cell responses in severe COVID-19 disease correlate with robust viral-specific antibody production but poor clinical outcomes
2020· 61 citedOpen Access

Frequent Co-authors

Matthew C. Woodruff(16), Natalie S. Haddad(16), Igñacio Sanz(16), Shuya Kyu(15), F. Eun‐Hyung Lee(14), Richard P. Ramonell(12), Doan C. Nguyen(11), Kevin S. Cashman(10), Andrea Morrison-Porter(9), John L. Daiss(9), Martin Runnstrom(9), Saeyun Lee(8), Scott A. Jenks(8), Christopher M. Tipton(8), Arezou Khosroshahi(8), John D. Roback(8), Hannah Quehl(8), Caterina E. Faliti(7), Ankur Singh Saini(6), Jennifer Hom(6)